Product features

  • Independent third-party control material: valid for any molecular testing platform
  • Purified nucleic acid, complete microbial genome
  • Any target can be amplified
  • Precise concentration in copies/µl by qPCR
  • Concentration range: 12,500-20,000 copies/µl
  • Non-infectious material provided with inactivation certificate
  • Lyophilized presentation ensures stability and reduces transport costs

> Sequencing data available to assist in probe and primer design:

Kit AMPLIRUN

PRODUCTS

AMPLIRUN® SARS-CoV-2 RNA CONTROL

CE
Purified RNA of coronavirus SARS-CoV-2 to be used to control techniques based in nucleic acids amplification.

Analytes: SARS-COV-2

Reference MBC137
Concentración 12,500-20,000 copies/μl
Volume 50 µl

AMPLIRUN® SARS-CoV-2 B.1.1.7 RNA CONTROL

RUO
Purified RNA of coronavirus SARS-CoV-2 B.1.1.7 lineage (also known as VOC 202012/01 or UK variant) to be used to control techniques based in nucleic acids amplification.
Reference MBC138-R
Concentración 12,500-20,000 copies/μl
Volume 50 µl

AMPLIRUN® SARS-CoV-2 B.1.351 RNA CONTROL

RUO
Purified RNA of coronavirus SARS-CoV-2 B.1.351 lineage (also known as V2, 20C/501Y.V2 or South African variant) to be used to control techniques based in nucleic acids amplification.
Reference MBC139-R
Concentración 12,500-20,000 copies/μl
Volume 50 µl

AMPLIRUN® SARS-CoV-2 P.1 RNA CONTROL

RUO
Purified RNA of coronavirus SARS-CoV-2 lineage P.1 (also known as 20J/501Y.V3 or Brazilian variant) to be used to control techniques based in nucleic acids amplification.
Reference MBC140-R
Concentración 12,500-20,000 copies/µl
Volume 50 µl

AMPLIRUN® SARS-CoV-2 DELTA (B.1.617.2) RNA CONTROL

RUO
Purified RNA of coronavirus SARS-CoV-2 lineage B.1.617.2 (also known as Delta, G/478K.V1 or Indian variant) to be used to control techniques based in nucleic acids amplification.
Reference MBC141-R
Concentración 12,500-20,000 copies/μl
Volume 50 µl

AMPLIRUN® SARS-CoV-2 OMICRON RNA CONTROL

RUO
Purified RNA of coronavirus SARS-CoV-2 lineage B.1.1.529 (BA.1) (also known as Omicron) to be used to control techniques based in nucleic acids amplification.
Reference MBC143-R
Concentración 12,500-20,000 copies/μl
Volume 50 µl

AMPLIRUN® SARS-CoV-2 OMICRON BA.2 RNA CONTROL

RUO
Purified RNA of coronavirus SARS‐CoV‐2 Omicron BA.2 to be used to control techniques based in nucleic acids amplification.
Reference MBC145-R
Concentración 12,500-20,000 copies/μl
Volume 50 µl

HOW IT WORKS

AMPLIRUN how to use vertical

MORE RESOURCES

Virus/Bacterias
RELATED VIRUSES/BACTERIA

Related germs and organisms categorized for this product line.

SARS-COV-2
Flyers
FLYERS

Downloadable PDF materials, brochures, and technical documents.

AMPLIRUN SARS-COV-2 & VARIANTS CONTROLS Brochure
AMPLIRUN SARS-COV-2 & VARIANTS CONTROLS Brochure
AMPLIRUN General Catalogue
AMPLIRUN General Catalogue
AMPLIRUN WEB
AMPLIRUN WEB
Blog
BLOG

The latest insights, news, and research articles from our scientific team.

Infecciones vaginales polimicrobianas: por qué importan los controles de terceros en diagnóstico molecular
02 July 2026

Infecciones vaginales polimicrobianas: por qué importan los controles de terceros en diagnóstico molecular

Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...

Beyond detection: H. pylori testing in today’s laboratory workflow
26 June 2026

Beyond detection: H. pylori testing in today’s laboratory workflow

Helicobacter pylori remains a highly relevant target in gastrointestinal diagnostics. It is a familiar pathogen, but its clinical importance has not d...

Aspergillus galactomannan: a practical biomarker for invasive aspergillosis diagnosis
15 May 2026

Aspergillus galactomannan: a practical biomarker for invasive aspergillosis diagnosis

Invasive aspergillosis is still one of the most difficult fungal infections to diagnose early. It mainly affects patients with weakened immune systems...

Bibliography
BIBLIOGRAPHY

Scientific bibliography and references related to this product.

Caballero Méndez, A.; Sosa Ortiz, M. N.; Reynoso de la Rosa, R. A.; Abreu Bencosme, M. E.; Montero Lebrón, K. V. From Triplex to Quadruplex: Enhancing CDC’s Respiratory qPCR Assay with RSV Detection on Panther Fusion® Open Access™. Preprints 2025.
Chung HY, Jian MJ, Chang CK, Lin JC, Yeh KM, Chen CW, et al. Multicenter study evaluating novel multi-specimen pooling assay for testing the detection of SARS-CoV-2: high sensitivity and high throughput. J Microbiol Immunol Infect. 2021;54(6):1004-11.
de Mello Malta F, Amgarten D, Val FC, Ferraz Santana RA, Castro Cervato M, Mascaro Cordeiro de Azevedo B, et al. Mass molecular testing for COVID-19 using NGS-based technology and a highly scalable workflow. Sci Rep. 2021;11:10488.